Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (221) clinical trials

A Phase 3 multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of Aducanumab in subject’s with Early Alzheimer’s Disease.

Phase N/A

NAVIGATE-AD is a 52 week (plus a 4 week follow up visit), double blind study where participants will be randomly assigned (like the flip of a coin) to receive either 1 of 2 doses of study drug (LY32022626) or a placebo (tablet containing no active ingredients, similar to a "sugar ...

Phase

NEUP11-AD2 is a 26 week (plus a 2 week Follow up Visit) double blind study where participants will be randomly assigned (like the flip of a coin) to receive either 1 of 3 doses of study drug (Piromelatine) or a placebo (tablet containing no active ingredients, similar to a sugar ...

Phase

Are you starting to experience memory problems? Are slight memory problems affecting your ability to do regular activities? Has anyone noticed a change in your memory? Do you have a family history of Alzheimer’s Disease? If so, you may be experiencing the first signs of memory loss. You may qualify ...

Phase

24 month study for patients with mild Alzheimer's disease.

Phase N/A

Looking for volunteers with evidence of early Alzheimer's disease to participate in a nationwide clinical research study.

Phase N/A

Enrolling men and women who have signs of early stage Alzheimer's Disease. The clinical trial is evaluating whether an investigational combined treatment slows down, arrests, or reverses early stage Alzheimer's disease.

Phase N/A

For some people, dementia and Alzheimer’s disease (AD) can make them feel restless or upset. The ITI-007-201 Agitation Study is looking at an investigational medication to see if it is safe and works well to help reduce how often people with dementia, including AD feel upset or anxious. If you ...

Phase N/A

This study is a 4-week, multicenter, randomized, double-blind, placebo-controlled, ascending dose, 4-period crossover study designed to evaluate the safety, tolerability, efficacy, and PK of JZP-110 (75, 150, and 300 mg) in the treatment of excessive sleepiness in adult subjects with idiopathic PD

Phase

Are you (or someone you know) agitated and/or anxious about memory changes due to dementia or Alzheimer’s disease? If so, please call Meridien Research to schedule a screening for a medical research st

Phase N/A